Serum Concentration-Dependent Inhibition of CYP2D6 by Bupropion and Doxepin: Implications for Venlafaxine and Risperidone Metabolism.
- DOI
- 10.1055/a-2812-9208
- Published
- 2026 Mar 2
- Container
- Pharmacopsychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1055/a-2812-9208,
title = {Serum Concentration-Dependent Inhibition of CYP2D6 by Bupropion and Doxepin: Implications for Venlafaxine and Risperidone Metabolism.},
author = {Zioris GN and Warrings B and Deckert J and Walther S and Unterecker S and Scherf-Clavel M},
year = {2026},
journal = {Pharmacopsychiatry},
doi = {10.1055/a-2812-9208},
url = {https://doi.org/10.1055/a-2812-9208}
}RIS
TY - JOUR TI - Serum Concentration-Dependent Inhibition of CYP2D6 by Bupropion and Doxepin: Implications for Venlafaxine and Risperidone Metabolism. AU - Zioris GN AU - Warrings B AU - Deckert J AU - Walther S AU - Unterecker S AU - Scherf-Clavel M PY - 2026 JO - Pharmacopsychiatry DO - 10.1055/a-2812-9208 UR - https://doi.org/10.1055/a-2812-9208 ER -
APA
GN, Z., B, W., J, D., S, W., S, U., & M, S. (2026). Serum Concentration-Dependent Inhibition of CYP2D6 by Bupropion and Doxepin: Implications for Venlafaxine and Risperidone Metabolism.. Pharmacopsychiatry. https://doi.org/10.1055/a-2812-9208
Source records
- pubmed · retrieved 2026-09-25T15:31:10.918Z